CF
MEDP icon

C.T. Fitzpatrick’s Medpace MEDP Stock Holding History

C.T. Fitzpatrick’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.1M Sell
141,743
-61,325
-30% -$28.3M 2.29% 12
2026
Q1 		$97.5M Buy
203,068
+155,762
+329% +$79.8M 2.58% 12
2025
Q4 		$26.6M Sell
47,306
-152,866
-76% -$86.8M 0.48% 29
2025
Q3 		$103M Sell
200,172
-87,287
-30% -$38.1M 1.87% 19
2025
Q2 		$96.9M Sell
287,459
-38,457
-12% -$11.5M 1.71% 19
2025
Q1 		$99.2M Buy
325,916
+224,578
+222% +$75.5M 1.86% 17
2024
Q4 		$33.7M Buy
101,338
+55,237
+120% +$18.7M 0.56% 31
2024
Q3 		$15.4M Buy
46,101
+7,501
+19% +$2.85M 0.26% 39
2024
Q2 		$15.9M Sell
38,600
-37,916
-50% -$15M 0.24% 39
2024
Q1 		$30.9M Sell
76,516
-25,744
-25% -$9.05M 0.45% 40
2023
Q4 		$31.3M Sell
102,260
-37,859
-27% -$10.2M 0.46% 39
2023
Q3 		$33.9M Sell
140,119
-51,889
-27% -$13.3M 0.52% 37
2023
Q2 		$46.1M Sell
192,008
-28,563
-13% -$5.93M 0.58% 32
2023
Q1 		$41.5M Buy
220,571
+67,229
+44% +$13.9M 0.52% 32
2022
Q4 		$32.6M Sell
153,342
-247,861
-62% -$49.5M 0.44% 33
2022
Q3 		$63.1M Sell
401,203
-14,605
-4% -$2.33M 0.74% 27
2022
Q2 		$62.2M Sell
415,808
-145,835
-26% -$21.1M 0.61% 30
2022
Q1 		$91.9M Buy
561,643
+329,023
+141% +$54.2M 0.56% 25
2021
Q4 		$50.6M Sell
232,620
-75,884
-25% -$15.9M 0.26% 35
2021
Q3 		$58.4M Buy
308,504
+83,328
+37% +$15.2M 0.31% 33
2021
Q2 		$39.8M Buy
+225,176
New +$38.9M 0.22% 37

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

C.T. Fitzpatrick's MEDP Position: Q2 2026 in Review

C.T. Fitzpatrick reduced its Medpace (MEDP) stake by 30% in Q2 2026, selling an estimated $28.3M and leaving 141,743 shares worth $75.1M. The position accounts for 2.29% of the portfolio, ranked #12.

C.T. Fitzpatrick first reported a position in MEDP in Q2 2021 and has held it in 21 quarters since. The position peaked at $103M in Q3 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • C.T. Fitzpatrick held 141,743 shares of Medpace worth $75.1M as of Q2 2026.
  • C.T. Fitzpatrick sold 61,325 Medpace shares in Q2 2026, an estimated $28.3M.
  • Medpace made up 2.29% of C.T. Fitzpatrick's portfolio in Q2 2026, its #12 holding.
  • C.T. Fitzpatrick first reported a position in Medpace in Q2 2021 and has held it in 21 quarters since.
  • C.T. Fitzpatrick's Medpace position peaked at $103M in Q3 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Vulcan Value Partners's 13F filing for Q2 2026, filed 10 Aug 2026.